Follow the 코미팜 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 코미팜 has logged 37 insider filings. Market capitalisation: €615.3bn. The latest transaction was reported on 11 March 2026 (Other). Among the most active insiders: 유경호. All data is accessible without an account.
37
Insider Decl.
0
Thresholds
·
21 ops.
Buy Volume
·
6 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 21,396 of 26,220 companies
29.5
score / 100
Value
30
Quality
29
FCF yld-1.0%
Earn yld-1.4%
EV/EBITDA·
ROE·
Gross mgn33%
Net mgn-14%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.